Ethanol and cognition: Indirect effects, neurotoxicity and neuroprotection: A review

International Journal of Environmental Research and Public Health

Volumn 7, Issue 4, 2010, Pages 1540-1557

  Brust, John C M ^a  

^a Harlem Hospital Center and Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Alcoholic dementia; Glutamate; Wernicke korsakoff

Indexed keywords

ALCOHOL; APOLIPOPROTEIN E4; POLYPHENOL; RESVERATROL; NEUROPROTECTIVE AGENT;

ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; ALZHEIMER DISEASE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM INFECTION; COGNITION; CORONARY ARTERY DISEASE; DEMENTIA; EXCITOTOXICITY; FETAL ALCOHOL SYNDROME; HUMAN; HYPOGLYCEMIA; LIVER FAILURE; MARCHIAFAVA BIGNAMI DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PELLAGRA; REVIEW; RISK REDUCTION; TERATOGENESIS; TRAUMATIC BRAIN INJURY; WERNICKE KORSAKOFF SYNDROME; DRUG EFFECTS; TOXICITY;

COGNITION; ETHANOL; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 77954556007     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph7041540     Document Type: Review

References (156)

1. Brust, J.C.M. Neurological Aspects of Substance Abuse, 2nd ed.; Butterworth-Heinemann: Boston, MA, USA, 2004; pp. 317-425.
2. Hanson, G.R.; Li, T.-K. Public health implications of excessive alcohol consumption. JAMA 2003, 289, 1031-1032.
3. Tupala, E.; Tiihonen, J. Dopamine and alcoholism: neurobiological basis of alcohol abuse. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28, 1221-1247.
4. Davis, K.M.; Wu, J.-Y. Role of glutamatergic and GABAergic systems in alcoholism. J. Biomed. Sci. 2001, 8, 7-19.
5. Koch-Weser, J.; Sellers, E.M.; Kalent, H.L. Alcohol intoxication and withdrawal. N. Engl. J. Med. 1976, 294, 757-762.
6. Fox, A.; Kay, J.; Taylor A. The course of alcohol withdrawal in a general hospital. QJM 1997, 90, 253-261.
7. Ng, S.K.C.; Hauser, W.A.; Brust, J.C.M.; Susser, M. Alcohol consumption and withdrawal in new onset seizures. N. Engl. J. Med. 1988, 319, 666-673.
8. Kosten, T.R.; O'Connor, P.G. Management of drug and alcohol withdrawal. N. Engl. J. Med. 2003, 348, 1786-1795.
9. Rivara, F.P.; Koepsell, T.D.; Jurkovich, G.; Gurney, J.G.; Soderberg, R. The effects of alcohol abuse on readmission for trauma. JAMA 1993, 270, 1962-1964.
10. Cook, R.T. Alcohol abuse, alcoholism and damage to the immune system-a review. Alcohol Clin. Exp. Res. 1998, 22, 1927-1942.
11. Malouf, R.; Brust, J.C.M. Hypoglycemia: causes, neurological manifestations, and outcome. Ann. Neurol. 1985, 17, 421-430.
12. Lizardi-Cervera, J.; Almeda, P.; Guevara, L.; Uribe, M. Hepatic encephalopathy: a review. Ann Hepatol. 2003, 2, 122-130.
13. Osborn, H.H. Ethanol. In Goldfrank's Toxicologic Emergencies, 6th ed.; Goldfrank, L.R., Flomenbaum, N.E., Lewin, N.A., Weisman, R.S., Howland, M., Hoffman, R.S., Eds.; Appleton & Lange: Stamford, CT, USA, 1998; pp. 1023-1041.
14. Kohler, C.G.; Ances, B.M.; Coleman, A.R.; Ragland, J.D.; Lazarev, M.; Gur, R.C. Marchiafava- Bignami disease: literature review and case report. Neuropsychiatry Neuropsychol. Behav. Neurol. 2000, 13, 67-76.
15. Serdaru, M.; Hausser-Hauw, C.; Laplane, D.; Buge, A.; Castaigne, P.; Goulan, M.; Lhermitte, F.; Hauw, J.J. The clinical spectrum of alcoholic pellagra encephalopathy. Brain 1988, 111, 829-842.
16. Victor, M.; Adams R.D.; Collins, G.H. The Wernicke-Korsakoff Syndrome, 2nd ed.; FA Davis: Philadelphia, PA, USA, 1989.
17. Caine, D.; Halliday, G.M.; Kril, J.J.; Harper, C.G. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J. Neurol. Neurosurg. Psychiatry 1997, 62, 51-60.
18. Homewood, J.; Bond, N.W. Thiamine deficiency and Korsakoff's syndrome: failure to find memory impairments following nonalcoholic Wernicke's encephalopathy. Alcohol 1999, 19, 75-84.
19. Kopelman, M.D. The Korsakoff syndrome. Br. J. Psychiatry 1995, 166, 154-173.
20. Robinson, J.K.; Mair, R.G. MK-801 prevents brain lesions and delayed-nonmatching-to-sample deficits produced by pyrithiamine-induced encephalopathy in rats. Behav. Neurosci. 1992, 106, 623-633.
21. Cheon, Y.; Park, J.; Joe, K.-H.; Kim, D.J. The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia. Int. J. Neuropsychopharmacol. 2008, 11, 971-983.
22. Rustembegovic, A.; Kundurovic, Z.; Sapcanin, A.; Sofic, E. A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome. Med. Arkhiv. 2003, 57, 149-150.
23. Cochrane, M.; Cochrane, A.; Jauhar P.; Ashton, E. Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome-three further cases show response to donezepil. Alcohol Alcohol. 2005, 40, 151-154.
24. Gibson, R.C.; Barnaby, L. Rivastigmine in the treatment of alcohol-induced persisting dementia. West Indian Med. J. 2003, 52, 59-61.
25. Victor, M.; Adams, R.D.; Mancall, E.L. A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. Arch. Neurol. 1959, 71, 579-588.
26. Mancall, E.L.; McEntee, W.J. Alterations of the cerebellar cortex in nutritional encephalopathy. Neurology 1965, 15, 303-313.
27. Dlugos, C.A.; Pentney, R.J. Morphometric evidence that the total number of neurons on Purkinje neurons of old F344 rats is reduced after long-term ethanol treatment and restores to control after recovery. Alcohol 1997, 32, 161-172.
28. Pantazis, N.J.; Dohrman, D.P.; Luo, J.; Thomas, J.D.; Goodlet, C.R.; West, J.R. NMDA prevents alcohol-induced neuronal cell death of cerebellar granule cells in culture. Alcohol Clin. Exp. Res. 1995, 19, 846-853.
29. Shimozono, M.; Townsend, J.C.; Ilsen, P.F.; Bright, D.C. Acute vision loss resulting from complications of ethanol abuse. J. Am. Optomet. Assoc. 1998, 69, 293-303.
30. Koike, H.; Iljima, M.; Sugiura, M.; Mori, K.; Hattori, N.; Ito, H.; Hirayama, M.; Sobue, G. Alcoholic neuropathy is clinicopathologically distinct from thiamine deficiency neuropathy. Ann. Neurol. 2003, 54, 19-29.
31. Gazdzinski, S.; Dorazzo, T.C.; Meyerhoff, D.J. Temporal dynamics and determinants of whole brain tissue volume changes during recovery from alcohol dependence. Drug Alcohol Depend. 2005, 78, 263-273.
32. Gupta, S.; Warner, J. Alcohol-related dementia: a 21st-century silent epidemic? Br. J. Psychiatry 2008, 193, 351-353.
33. Harper, C.J.; Kril, J.; Daly, J. Are we drinking our neurons away? BMJ 1987, 294, 539-536.
34. Smith, D.M.; Atkinson, R.M. Alcoholism and dementia. Int. J. Addict. 1995, 30, 1843-1869.
35. Oslin, D.W.; Atkinson, R.M.; Smith, D.M.; Hendrie, H. Alcohol related dementia: proposed clinical criteria. Int. J. Geriatric Psychiatry 1998, 13, 203-212.
36. File, S.E.; Mabbutt, P.S. Long-lasting effects on habituation and passive avoidance performance of a period of chronic ethanol administration in the rat. Behav. Brain Res. 1990, 36, 171-178.
37. Walker, D.W.; Hunter, B.E.; Abraham, W.C. Neuroanatomical and functional deficits subsequent to chronic ethanol administration in animals. Alcohol Clin. Exp. Res. 1981, 5, 267-282.
38. Phillips, S.C. The threshold concentration of dietary ethanol necessary to produce toxic effects of hippocampal cells and synapses in the mouse. Exp. Neurol. 1989, 104, 68-72.
39. Durand, D.; Saint-Cyr, J.A.; Gurevich, N.; Carlen, P.L. Ethanol-induced dendritic alterations in hippocampal granule cells. Brain Res. 1989, 477, 373-377.
40. Bengoechea, O.; Gonzalo, L.M. Effects of alcoholization in the rat hippocampus. Neurosci. Lett. 1991, 123, 112-114.
41. Collins, M.A.; Corso, T.D.; Neafsey, E.J. Neuronal degeneration in rat cerebrocortical and olfactory regions during subchronic "binge" intoxication with ethanol: possible explanation for olfactory deficits in alcoholics. Alcohol Clin. Exp. Res. 1996, 20, 284-292.
42. Ferrer, I.; Galofre, E.; Fabriques; Lopez-Tejero, D. Effects of chronic ethanol consumption beginning at adolescence: increased numbers of dendritic spines on cortical pyramidal cells in adulthood. Acta. Neuropathol. 1989, 78, 528-532.
43. Lundqvist, C.; Alling, C.; Knoth; Volk, B. Intermittent ethanol exposure of adult rats. Hippocampal cell loss after one month of treatment. Alcohol 1995, 30, 737-748.
44. Arendt, T.; Henning, D.; Gray, J.A.; Marchbanks, R. Loss of neurons in the rat basal forebrain cholinergic projection system after prolonged intake of ethanol. Brain Res. Bull. 1988, 21, 563-569.
45. Benthius, D.J.; West, J.R. Ethanol-induced neuronal loss in the developing rats: increased brain damage with binge exposure. Alcohol Clin. Exp. Res. 1990, 14, 107-118.
46. Harper, C. The neurobiology of alcohol-specific brain damage, or does alcohol damage the brain? J. Neuropathol. Exp. Neurol. 1998, 57, 101-110.
47. Ravaglia, S.; Costa, A.; Ratti, M.T.; Savoldi, E.; Bo, P.; Moglia, A. Cognitive impairment and central motor conduction time in chronic alcoholics. Funct. Neurol. 2002, 17, 83-86.
48. Sullivan, E.V. Compromised pontocerebellar and cerebellothalamocortical systems: speculations on their contribution to cognitive and motor impairment in nonamnesic alcoholism. Alcohol Clin. Exp. Res. 2003, 27, 1409-1419.
49. Kril, J.J.; Halliday, G.M. Brain shrinkage in alcoholics: a decade on and what have we learned? Prog. Neurobiol. 1999, 58, 381-387.
50. Pfefferbaum, A.; Sullivan, E.V.; Hedehus, M.; Adalsteinsson, E.; Lim, K.O.; Moseley, M. In vivo detection and functional correlates of white matter microstructural disruption in chronic alcoholism. Alcohol Clin. Exp. Res. 2000, 24, 1214-1221.
51. Shear, P.K.; Jernigan, T.L.; Butters, N. Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholics. Alcohol Clin. Exp. Res. 1994, 18, 172-176.
52. Di Scalfani, V.; Ezekiel, F.; Meyerhoff, D.J.; Mackay, S.; Dillonv, V.V.P.; Weimer, M.W.V.; Fein, G. Brain atrophy and cognitive function in older abstinent alcoholic men. Alcohol Clin. Exp. Res. 1995, 19, 1121-1126.
53. Estilaei, M.R.; Matson G.B.; Payne, G.S.; Leach, M.O.; Fein, G.; Meyerhoff, D.J. Effects of chronic alcohol consumption on the broad phospholipid signal in human brain: an in vivo 31P MRS study. Alcohol Clin. Exp. Res. 2001, 25, 89-97.
54. Pfefferbaum, A.; Sullivan, E.V. Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism: evidence from diffusion tensor imaging. Neuropsychopharmacology 2005, 30, 423-432.
55. Harper, C.; Matsumoto, I. Ethanol and brain damage. Curr. Op. Pharmacol. 2005, 5, 73-78.
56. Schweinsburg, B.C.; Taylor, M.J.; Alhassoon, O.M.; Videan, J.S.; Brown, G.G.; Patterson, T.L.; Berger F.; Grant, T. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin. Exp. Res. 2001, 25, 924-934.
57. Bron, A.; Anderson, J. Frontal dysfunction and frontal cortical synapse loss in alcoholism: the main cause of alcohol dementia? Dement. Geriatr. Cogn. Disord. 2001, 12, 289-294.
58. Monnot, M.; Nixon, S.; Lovallo, W.; Ross, E. Altered emotional perception in alcoholics: deficits in affective prosody comprehension. Alcohol Clin. Exp. Res. 2001, 25, 362-369.
59. Harper, C.; Corbett, D. Changes in the basal dendrites of cortical pyramidal cells from alcoholic patients-a quantitative Golgi study. J. Neurol. Neurosurg. Psychiatry 1990, 53, 856-861.
60. Mann, K.; Ackerman, B.; Croissant, B.; Mundle, G.; Nakovics, H.; Diehl, A. Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin. Exp. Res. 2005, 29, 896-901.
61. Duka, T.; Townshend, J.M.; Collier, K.; Stephens, D.N. Impairment in cognitive functions after multiple detoxifications in alcoholic inpatients. Alcohol Clin. Exp. Res. 2003, 27, 1563-1572.
62. Tsai, G.; Coyle J.T. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu. Rev. Med. 1998, 49, 173-184.
63. Chandler, L.J.; Newsom, H.; Sumners, C.; Crews, F. Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neurons. J. Neurochem. 1993, 60, 1578-1581.
64. Gotz, M.E.; Janetsky, B.; Pohli, S.; Gottschalk, A.; Gsell, W.; Tatschner, T.; Ransmayr, G.; Leblhuber, F.; Gerlach, M.; Reichmann, H.; Riederer, P.; Böning, J. Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link? Alcohol Clin. Exp. Res. 2001, 25, 717-725.
65. Stepanyan, T.D.; Farook, J.M.; Kowalski, A.; Kaplan, E.; Barron, S.; Littleton, J.M. Alcohol withdrawal-induced hippocampal neurotoxicity in vitro and seizures in vivo are both reduced by memantine. Alcohol Clin. Exp. Res. 2008, 32, 2128-2135.
66. Krupitsky, E.M.; Neznanova, O.; Masalov, D.; Burakov, A.M.; Didenko, T.; Romanova, T.; Tsoy, M.; Bespalov, A.; Slavina, T.Y.; Grinenko, A.A.; Petrakis, I.L.; Pittman, B.; Gueorguieva, R.; Zvartau, E.E.; Krystal, J.H. Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients. Am. J. Psychiatry 2007, 164, 519-523.
67. Bleich, S.; Bandelow, B.; Javaheripour, K.; Müller, A.; Degner, D.; Wilhelm, J.; Havemann-Reinecke, U.; Spurling, W.; Ruther, E.; Kornhuber, J. Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism. Neurosci. Lett. 2003, 335, 179-182.
68. Robinson, G.; Narasimhan, S.; Weatherall, M.; Beasley, R. Raised plasma homocysteine levels in alcoholism: increasing the risk of heart disease and dementia? N. Z. Med. J. 2005, 118, U1490.
69. Wilhelm, J.; Bayerlein, K.; Hillemacher, T.; Reulback, U.; Friehling, H.; Kromdan, B.; Degner, D.; Kornhuber, J.; Bleich, S. Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism. J. Neurol. Transmission 2006, 113, 357-363.
70. Miller, R.; King, M.A.; Heaton, M.B.; Walker, D.W. The effects of chronic ethanol consumption on neurotrophins and their receptors in the rat hippocampus and basal forebrain. Brain Res. 2002, 950, 137-147.
71. Lamarche, F.; Gonthier, B.; Signorini, N.; Eysseric, H.; Barret, L. Acute exposure of cultured neurons to ethanol results in reversible DNA single-strand breaks; whereas chronic exposure causes loss of cell viability. Alcohol Alcohol. 2003, 38, 550-558.
72. Niemela, O. Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic. Biol. Med. 2001, 31, 1533-1538.
73. Butterworth, R.F. Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease. Metab. Brain Dis. 1995, 10, 1-8.
74. Harper, C.; Dixon, G.; Sheedy, D.; Garrick, T. Neuropathological alterations in alcoholic brains. Studies arising from New South Wales Tissue Resource Centre. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27, 951-961.
75. Parsons, O.A.; Nixon, S.J. Cognitive functioning in sober social drinkers: a review of the research since 1986. J. Stud. Alcohol 1998, 59, 180-190.
76. Kubota, M.; Nakazaki, S.; Hirai, S.; Saeki, N.; Yamaura, A.; Kusaka, T. Alcohol consumption and frontal lobe shrinkage: study of 1432 non-alcoholic subjects. J. Neurol. Neurosurg. Psychiatry 2001, 71, 104-106.
77. Launer, L.J.; Feskens, E.J.; Kalmijn, S.; Kromhout, D. Smoking, drinking, and thinking: the Zutphen Elderly Study. Am. J. Epidemiol. 1996, 143, 219-227.
78. Galanis, D.J.; Joseph, C.; Masaki, K.H.; Petrovitch, H.; Ross, G.W.; White, L. A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu- Asia Aging Study. Am. J. Public Health 2000, 90, 1254-1259.
79. Lemeshow, S.; Letenneur, L.; Dartigues, J.F.; Lafont, S.; Orgogozo, J.M.; Commenges, D. Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Am. J. Epidemiol. 1998, 148, 298-306.
80. Ruitenberg, A.; van Swieten, J.C.; Witteman, J.C.M.; Mehta, K.M.; van Duijn, C.M.; Hoffman, A.; Breteler, M.M. Alcohol consumption and the risk of dementia: the Rotterdam Study. Lancet 2002, 359, 281-286.
81. Truelson, T.; Thudium, D.; Gronbaek, M. Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 2002, 59, 1313-1319.
82. Mukamal, K.J.; Kuller, L.H.; Fitzpatrick, A.L.; Longstreth, W.T.; Mittleman, M.A.; Siscovick, D.S. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003, 289, 1405-1413.
83. Espeland, M.A.; Gu, L.; Masaki, K.H. Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study. Am. J. Epidemiol. 2005, 161, 228-238.
84. Bond, G.E.; Burr, R.L.; McCurry, S.M.; Rice, M.M.; Borenstein, A.R.; Larson, E.B. Alcohol and cognitive performance: a longitudinal study of older Japanese Americans. The Kame Project. Int. Psychogeriatr. 2005, 17, 653-668.
85. Leroi, I.; Sheppard, J.M.; Lyketsos, C.G. Cognitive function after 11.5 years of alcohol use: relation to alcohol use. Am. J. Epidemiol. 2002, 156, 747-752.
86. Kalmijn, S.; van Boxtel, M.P.J.; Verschuren, M.W.M.; Jolles, J.; Launer, L.J. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. Am. J. Epidemiol. 2002, 156, 936-944.
87. Collins, M.A.; Neafsey, E.J.; Mukamal, K.J.; Gray, M.O.; Parks, D.A.; Das, O.K.; Korthuis, R.J. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin. Exp. Res. 2009, 33, 206-219.
88. Cleophas, T.J. Wine, beer and spirits and the risk of myocardial infarction: a systematic review. Biomed. Pharmacother. 1999, 53, 417-423.
89. Corrao, G.; Rubbiati, L.; Bagnardi, V.; Zambon, A.; Poikolainen, K. Alcohol and coronary artery disease: a meta-analysis. Addiction 2000, 95, 1505-1523.
90. Freiberg, M.S.; Samet, J.H. Alcohol and coronary heart disease: the answer awaits a randomized controlled trial. Circulation 2005, 112, 1379-1381.
91. Fillmore K.M.; Stockwell, T.; Chikritzhs, T.; Bostrom, A.; Kerr, W. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses. Ann. Epidemiol. 2007, 17, S16-S23.
92. Mukamal, K.J.; Conigrave, K.M.; Mittleman, M.A.; Camargo, C.A., Jr.; Stamfer, M.J.; Willett, W.C.; Rimm, E.B. Roles of drinking and type of alcohol consumed in coronary heart disease in men. N. Engl. J. Med. 2003, 348, 109-118.
93. Mukamal, K.J.; Chung, H.; Jenny, N.S.; Kuller, L.H.; Longstreth, W.T., Jr.; Mittleman, M.A.; Burke, G.L; Cushman, M.; Psaty, B.M.; Siskovic, D.S. Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study. J. Am. Geriatr. Soc. 2006, 54, 30-37.
94. Mukamal, K.J.; Jensen, M.K.; Gronback, M.; Stamfer, M.J.; Manson, J.E.; Pischon, T.; Rimm, E.B. Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation 2005, 112, 1406-1413.
95. Davies, M.J.; Baer, D.J.; Judd, J.T.; Brown, E.D.; Campbell, W.S.; Taylor, P.R. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA 2002, 287, 2559-2562.
96. Renaud, S.C.; Ruf, J.C. Effects of alcohol on platelet function. Clin. Chim. Acta. 1996, 246, 77-89.
97. Aikens, M.L.; Grenett, H.E.; Benza, R.L.; Tabengua, E.M.; Davis, G.C.; Booyse, F.M. Alcohol-induced upregulation of plasminogen activators and fibrinolytic activity in cultured human endothelial cells. Alcohol Clin. Exp. Res. 1998, 22, 375-381.
98. Sierksma, A.; van der Gaag, M.S.; Kluft, C.; Hendricks, H.F. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels: a randomized, diet-controlled intervention study. Eur. J. Clin. Nutr. 2002, 56, 1130-1136.
99. Das, S.; Khan, N.; Mukherjee, S.; Bagchi, D.; Gurusamy, N.; Swartz, H.; Das, D.K. Redox regulation of resveratrol-mediated switching of death signal into survival signal. Free Radic. Biol. Med. 2008, 44, 82-90.
100. Juric, D.; Wojciechowski, P.; Das, D.K.; Nettícadan, T. Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol. Am. J. Physiol. Heart. Circ. Physiol. 2007, 292, H2138-H2143.
101. Mokni, M.; Limam, F.; Elkahoui, S.; Amri, M.; Aouani, E. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia-reperfusion injury. Arch. Biochem. Biophys. 2007, 457, 1-6.
102. Tsai, S.-K.; Hung, L.-M.; Fu, Y.-T.; Cheng, H.; Nien, M.W.; Liu, H.Y.; Zhang, F.B.; Huang, S.S. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J. Vasc. Surg. 2007, 46, 346-353.
103. Reynolds, K.; Lewis, B.; Nolen, J.D.; Kinney, G.L.; Sathya, B; He, J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003, 289, 579-588.
104. Mukamal, K.J.; Ascherio, A.; Mittleman, M.A.; Conigrave, K.M.; Camargo, C.A., Jr.; Kawachi, I.; Stamfer, M.J.; Willett, W.C.; Rimm, E.B. Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage. Ann. Intern. Med. 2005, 142, 11-19.
105. Mukamal, K.J.; Chung, H.; Jenny, N.S.; Kuller, L.H.; Longstreth, W.T., Jr.; Mittleman, M.A.; Burke, G.L.; Cushman, M.; Beauchamp, N.J., Jr. Alcohol use and risk of ischemic stroke among older adults. The Cardiovascular Health Study. Stroke 2005, 36, 1830-1834.
106. Wang, Q.; Sun, A.Y.; Simonyi, A.; Kalogeris, T.J.; Miller, D.K.; Sun, G.Y.; Korthuis, R.J. Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radic. Biol. Med. 2007, 43, 1048-1060.
107. Orgogozo, J.M.; Dartigues, J.F.; LaFont, S.; Letenneur, L.; Commenges, D.; Salamon, R.; Renaud, S.; Breteler, M.B. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev. Neurol. 1997, 153, 185-192.
108. Larrieu, S.; Letenneur, L.; Helmer, C.; Dartigues, J.F.; Barberger-Gateau, P. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J. Nutr. Health Aging 2004, 8, 150-154.
109. Dufouil, C.; Tzourio, C.; Brayne, C.; Berr, C.; Amouyel, P.; Alperovitch, A. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology 2000, 11, 280-284.
110. Carmelli, D.; Swan, G.E.; Reed, T.; Schellenberg, G.D.; Christian, J.C. The effect of apolipoprotein Eε4 in the relationships of smoking and drinking to cognitive function. Neuroepidemiology 1999, 18, 125-133.
111. Zu, G.; Liu, X.; Yin, Q.; Zhu, W.; Zhang, R.; Fan, X. Alcohol consumption and transition of mild cognitive impairment to dementia. Psychiatry Clin. Neurosci. 2009, 63, 43-49.
112. Solfrizzi, V.; D'Introno, A.; Colacicco, M.; Capurso, C.; Del Parigi, A.; Baldassarre, G.; Scapicchio, P.; Scafato, E.; Amodio, M.; Capurso, A.; Panza, F. Italian Longitudinal Study on Aging Working Group. Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology 2007, 68, 1790-1799.
113. Panza, F.; Capurso, C.; D'Introno, A.; Colacicco, A.M.; Frisardi, V.; Lorusso, M.; Santamato, A.; Seripa, D.; Pilotto, A.; Scarfato, E.; Vendemiate, G.; Capurso, A.; Solfrizzi, V. Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes. J. Alzheimer Dis. 2009, 17, 7-31.
114. Stampfer, M.J.; Kang, J.H.; Chen, J. Effects of moderate alcohol consumption on cognitive function in women. N. Engl. J. Med. 2005, 352, 245-253.
115. Luchsinger, J.A.; Tang, M.-X.; Siddiqui, M.; Shea, S.; Mayeux, R. Alcohol intake and risk of dementia. J. Am. Geriatr. Soc. 2004, 52, 540-546.
116. Mehlig, K.; Skoog, I.; Guo, X.; Schutze, M.; Gustofson, D.; Waern, M.; Ostling, S.; Bjorkelund, C.; Lissner, L. Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Göteborg. Am. J. Epidemiol. 2008, 167, 684-691.
117. Peters, R.; Peters, J.; Warner, J.; Beckett, N.; Bulpitt, C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Aging 2008, 37, 505-512.
118. Ganguli, M.; Vander Bilt, J.; Saxton, J.; Shen, C.; Dodge, H.H. Alcohol consumption and cognitive function in late life: a longitudinal community study. Neurology 2005, 65, 1210-1217.
119. Singh, A.K.; Jiang, Y.; Gupta, S.; Benlhabib, E. Effects of chronic ethanol drinking on the blood brain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intraperitoneal LPS injection. Alcohol Alcohol. 2007, 42, 385-399.
120. Belmadani, A.; Neafsey, E.J.; Collins, M.A. Human immunodeficiency virus type 1 gp120 and ethanol coexposure in rat organotypic brain slice cultures: curtailment of gp120-induced neurotoxicity and neurotoxic mediators by moderate but not high ethanol concentrations. J. Neurovirol. 2003, 9, 45-54.
121. Belmadani, A.; Kumar, S.; Schipma, M.; Collins, M.A.; Neafsey, E.J. Inhibition of amyloid-beta- induced neurotoxicity and apoptosis by moderate ethanol preconditioning. Neuroreport 2004, 15, 2093-2096.
122. Paul, C.A.; Au, R.; Fredman, L.; Massaro, J.M.; Seshadri, S.; DeCarli, C.; Wolf, P.A. Association of alcohol consumption with brain volume in the Framingham Study. Arch. Neurol. 2008, 65, 1363-1367.
123. Mukamal, K.J.; Longstreth, W.T., Jr.; Mittleman, M.A.; Crum, R.M.; Siscovic, D.S. Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the Cardiovascular Health Study. Stroke 2001, 32, 1939-1946.
124. Ding, J.; Eigenbrodt, M.; Mosley, T.H., Jr.; Hutchinson, R.G.; Folsom, A.R.; Nieto, F.G. Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a community-based population of middle-aged adults. Stroke 2004, 35, 16-21.
125. Taki, Y.; Kinomura, S.; Sato, K.; Goto, R.; Inoue, K.; Okada, K.; Ono, S.; Kawashima, R.; Fukuda, H. Both global gray matter volume and regional gray matter volume negatively correlate with lifetime alcohol intake in non-alcohol-dependent Japanese men: a volumetric analysis and a voxel-based morphometry. Alcohol Clin. Exp. Res. 2006, 30, 1045-1050.
126. Ansley, K.J.; Jorm, A.; Reglade-Mesin, R.; Maller, J.; Kumar, R.; von Sanden, C.; Windsor, T.D.; Rodgers, B.; Wen, W.; Sachdev, P. Weekly alcohol consumption, brain atrophy and white matter hyperintensities in a community-based sample aged 60 to 64 years. Psychosom. Med. 2006, 68, 778-785.
127. den Heijer, T.; Vermeer, S.E.; van Dijk, E.J.; Prins, N.D.; Koudstaal, P.J.; van Duijn, CM.; Hofman, A.; Breteler, M.M. Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia. Am. J. Clin. Nutri. 2004, 80, 992-997.
128. Colangelo, W.; Jones, D.G. The fetal alcohol syndrome: a review and assessment of the syndrome and its neurological sequelae. Prog. Neurobiol. 1982, 19, 271-314.
129. Mattson, S.N.; Riley, E.P.; Gramling, L.; Delis, D.C.; Jones, K.L. Neuro-psychological comparison of alcohol-exposed children with and without physical features of fetal alcohol syndrome. Neuropsychology 1998, 12, 146-153.
130. Lemoine, P.; Lemoine, P. Avenir des enfants de mères alcoholiques (étude de 105 cas retrouvés a l'age adult) et quelques constatations d'intérêt prophylactique. Ann. Pediatr. 1992, 29, 226-235.
131. D'Onofrio, B.M.; van Hulle, C.A.; Waldman, I.D.; Rodgers, J.L.; Rathouz, P.J.; Lahey, B.B. Causal inferences regarding prenatal alcohol exposure and childhood externalizing problems. Arch. Gen. Psychiatry 2007, 64, 1296-1304.
132. Riley, E.P.; McGee, C.L. Fetal alcohol spectrum disorders; an overview with emphasis on changes in brain and behavior. Exp. Biol. Med. 2005, 230, 357-365.
133. O'Malley, K.D.; Nanson, J. Clinical implications of a link between fetal alcohol spectrum disorder and attention-deficit hyperactivity disorder. Can. J. Psychiatry 2002, 47, 349-354.
134. Mattson, S.N.; Schoenfeld, A.M.; Riley, E.P. Teratogenic effects of alcohol on brain and behavior. Alcohol Res. Health 2001, 25, 185-191.
135. O'Callaghan, F.V.; O'Callaghan, M.; Najman, J.M.; Williams, G.M.; Bor, W. Maternal alcohol consumption during pregnancy and physical outcomes up to 5 years of age: a longitudinal study. Early Hum. Dev. 2003, 71, 137-148.
136. O'Callaghan, F.V.; O'Callaghan, M.; Najman, J.M.; Williams, J.M.; Bor, W. Prenatal alcohol exposure and attention, learning, and intellectual ability at 14 years: a prospective longitudinal study. Early Hum. Dev. 2007, 83, 115-123.
137. Cudd, T.A. Animal model systems for the study of alcohol teratology. Exp. Biol. Med. 2005, 230, 389-393.
138. Berman, R.F.; Hannigan, J.H. Effects of prenatal alcohol exposure on the hippocampus: spatial behavior, electrophysiology, and neuroanatomy. Hippocampus 2000, 10, 94-110.
139. Kumada, T.; Jiang, Y.; Cameron, D.B.; Kamuro, H. How does alcohol impair neuronal migration? J. Neurosci. Res. 2007, 85, 465-470.
140. Hoffman, E.J.; Mintz, CD.; Wang, S.; McNickle, D.G.; Salton, S.R.; Benson, D.L. Effects of ethanol on axon outgrowth and branching in developing rat cortical neurons. Neuroscience 2008, 157, 556-565.
141. Luo, J. GSK3β in ethanol neurotoxicity. Mol. Neurobiol. 2009, 40, 108-121.
142. Clarren, S.K.; Bowden, D.M. Fetal alcohol syndrome: a new primate model for binge drinking and its relevance to human ethanol teratogenesis. J. Pediatr. 1982, 2, 203-213.
143. Sulik, K.K.; Lauder, J.M.; Dehart, D.B. Brain malformations in prenatal mice following acute maternal ethanol administration. Int. J. Dev. Neurosci. 1984, 2, 203-213.
144. Sulik, K.; Johnston, M.C; Webb, M.A. Fetal alcohol syndrome: embryogenesis in a mouse model. Science 1981, 214, 936-938.
145. Wright, J.T.; Waterson, E.J.; Barrison, I.G.; Toplis, P.J.; Lewis, I.G.; Gordon, M.G.; MacRae, K.D.; Morris, N.F.; Murray-Lyon, I.M. Alcohol consumption, pregnancy, and low birthweight. Lancet 1983, 1, 663-665.
146. Alpert, J.; Zuckerman, B. High blood alcohol levels in women. N. Engl. J. Med. 1990, 323, 60-66.
147. Mills, J.L.; Graubard, B.I.; Harley, E.E.; Rhoads, G.G.; Berendes, H.W. Maternal alcohol consumption and birthweight: how much drinking during pregnancy is safe? JAMA 1984, 252, 1875-1879.
148. Little, R.E.; Asker, R.L.; Sampson, P.D.; Renwick, J.H. Fetal growth and moderate drinking in early pregnancy. Am. J. Epidemiol. 1986, 123, 270-278.
149. Gray, R.; Mukherjee, R.A.S.; Rutter, M. Alcohol consumption during pregnancy and its effects on neurodevelopment: what is known and what remains uncertain. Addiction 2009, 104, 1270-1273.
150. Abel, E.L. Fetal alcohol syndrome: same old, same old. Addiction 2009, 104, 1274-1280.
151. May, P.A.; Gossage, J.P. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res. Health 2001, 25, 159-167.
152. Elliott, E.J.; Payne, J.; Morris, A.; Haan, E.; Bower, C. Fetal alcohol syndrome: a prospective national surveillance study. Arch. Dis. Child. 2008, 93, 732-737.
153. May, P.A.; Fiorentino, D.; Gossage, J.P.; Kalberg, W.O.; Hoyme, H.; Robinson, L.K.; Coriale, G.; Jones, K.L.; del Campo, M.; Tarani, L. Epidemiology of FASD in a province in Italy: prevalence and characteristics of children in a random sample of schools. Alcohol Clin. Exp. Res. 2006, 30, 1562-1575.
154. Mukherjee, A.B.; Hodgen, G.D. Maternal ethanol exposure induces transient impairment of umbilical circulation and fetal hypoxia in monkeys. Science 1982, 218, 700-702.
155. Kumari, M.; Tucku; M.K. Ethanol and regulation of the NMDA receptor subunits in fetal cortical neurons. J. Neurochem. 1998, 70, 1467-1473.
156. Yeaney, N.K.; He, M.; Tang, N.; Malouf, A.T.; O'Riorden, M.A.; Lemmon, V.; Bearer, C.F. Ethanol inhibits L1 cell adhesion molecule tyrosine phosphorylation and dephosphorylation and activation of pp60src. J. Neurochem. 2009, 110, 779-790.